JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(1):39-42

Power Law Equation and Liberation Kinetics

Z. Zatloukal
Katedra farmaceutické technologie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové

For the modelling of the kinetics of diffusion and relaxation in the polymer matrix, the power law equation in a two-parameter or three-parameter form is employed. The introductory part of the paper summarizes the employed varieties of the power law equation including the equation making it possible to distinguish diffusion from relaxation. The liberation kinetics of pilocarpinium chloride from lyophilized lamellae with graded amounts of hydroxypropylmethylcellulose is expressed by power law equations and their parameters are compared. The conclusion discusses the usability of the power law equation in the modelling of liberation of active ingredients and recommends the use of the three-parameter power law equation with a shift of the liberation out of the origin of the coordinates.

Keywords: power law equation; liberation kinetics; pilocarpinium chloride; hydroxypropylmethylcellulose

Received: January 21, 2004; Accepted: April 7, 2004; Published: January 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zatloukal Z. Power Law Equation and Liberation Kinetics. Čes. slov. farm. 2005;54(1):39-42.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Peppas, N. A.: Pharm. Acta Helv.,1985; 60, 110-111. Go to original source...
    2. Korsmeyer, R. W. et al.: Int. J. Pharm., 1983; 15, 25-35. Go to original source...
    3. Ritger, P. L., Peppas, N. A.: J. Control. Rel., 1987; 5, 23-36. Go to original source...
    4. Ritger, P. L., Peppas, N. A.: J. Control. Rel., 1987; 5, 37-42. Go to original source...
    5. Ford, J. L. et al.: Int. J. Pharm., 1987; 40, 223-234. Go to original source...
    6. Ranga Rao, K. V., Padmalatha Devi, K., Buri, P.: J. Control. Rel., 1990; 12, 133-141. Go to original source...
    7. Heng, P. W. S. et al.: J. Control. Rel., 2001; 76, 39-49. Go to original source... Go to PubMed...
    8. Juarez, H., Rico, G., Villafuerte, L.: Int. J. Pharm., 2001; 216, 115-125. Go to original source... Go to PubMed...
    9. Takka, S., Rajbhandari, S., Sakr, A.: Eur. J. Pharm. Biopharm., 2001; 52, 75-82. Go to original source... Go to PubMed...
    10. Singh, B., Ahuja, N.: Drug. Dev. Ind. Pharm., 2002; 28, 431 aÏ 442. Go to original source... Go to PubMed...
    11. Gonzales, I. M., Robles, L. V.: Int. J. Pharm., 2003; 251, 183 aÏ 193. Go to original source... Go to PubMed...
    12. Rinaki, E., Valsami, G., Macheras, P.: Int. J. Pharm., 2003; 255, 199-207. Go to original source... Go to PubMed...
    13. Möckel, J. E., Lippold, B. C.: Pharm. Res., 1993; 10, 1066 aÏ 1070. Go to original source... Go to PubMed...
    14. Talukdar, M. M. et al.: Int. J. Pharm., 1996; 129, 233-241. Go to original source...
    15. Sujja - Areevath, J. et al.: Eur. J. Pharm. Sci., 1998, 6, 207-217. Go to original source... Go to PubMed...
    16. Vervoort, L. et al.: Int. J. Pharm., 1998; 172, 127-135. Go to original source...
    17. Cox, P. J. et al.: Int. J. Pharm., 1999; 193, 73-84. Go to original source... Go to PubMed...
    18. Rao, V. M., Engh, K., Qiu, Y.: Int. J. Pharm., 2003; 252, 81-86. Go to original source... Go to PubMed...
    19. Catellani, P. et al.: Acta Pharm. Technol., 1988; 34, 38-41.
    20. Harland, R. S. et al.: Pharm. Res., 1988; 5, 488-494. Go to original source... Go to PubMed...
    21. Peppas, N. A., Sahlin, J. J.: Int. J. Pharm., 1989; 57, 169-172. Go to original source...
    22. Okimoto, K. et al.: Int. J. Pharm.,1997; 159, 85-93. Go to original source...
    23. Castellano, I. et al.: Drug Dev. Ind. Pharm., 1999; 25, 1249 aÏ 1257. Go to original source... Go to PubMed...
    24. Pillay, V., Fassihi, R.: J. Pharm. Sci., 1999; 88, 1140 aÏ 1148. Go to original source... Go to PubMed...
    25. Colombo, P. et al.: Pharm. Sci. Technol. Today, 2000; 3, 198 aÏ 204. Go to original source... Go to PubMed...
    26. Ferrero, C., Munoz - Ruiz, A., Jiménez - Castellanos, M. R.: Int. J. Pharm., 2000; 202, 21-28. Go to original source... Go to PubMed...
    27. Munday, D. L., Cox. P. J.: Int. J. Pharm., 2000; 203, 179-192. Go to original source... Go to PubMed...
    28. Pillay, V., Fassihi, R.: J. Control. Rel., 2000; 67, 67-78. Go to original source... Go to PubMed...
    29. Siepmann, J., Peppas, N. A.: Adv. Drug Del. Rev., 2001; 48, 139-157. Go to original source... Go to PubMed...
    30. Gazzaniga, A. et al.: Int. J. Pharm., 1993; 91, 167-171. Go to original source...
    31. Menon, A., Ritschel, W. A., Sakr, A.: J. Pharm. Sci., 1994; 83, 239-245. Go to original source... Go to PubMed...
    32. Perez - Marcos, B. et al.: Int. J. Pharm., 1994; 111, 251-259. Go to original source...
    33. Perez - Marcos, B. et al.: J. Pharm. Sci., 1996; 85, 330-334. Go to original source... Go to PubMed...
    34. Kim, H., Fassihi, R.: J. Pharm. Sci., 1997; 86, 316-322. Go to original source... Go to PubMed...
    35. Kim, H., Fassihi, R.: J. Pharm. Sci., 1997; 86, 323-328. Go to original source... Go to PubMed...
    36. Tros De Iiarduya, M. C. et al.: Drug Dev. Ind. Pharm., 1997; 23, 393-396. Go to original source...
    37. Velasco, M. V., Ford, J.L., Rajabi - Siahboomi, A. R.: Pharm. Pharmacol. Commun., 1998; 4, 377-383.
    38. Velasco, M. V. et al.: J. Control. Rel., 1999; 57, 75-85. Go to original source... Go to PubMed...
    39. Costa, P., Sousa Lobo, J. M.: Eur. J. Pharm. Sci., 2001; 13, 123 aÏ 133. Go to original source... Go to PubMed...
    40. Sadeghi, F. et al.: Drug Dev. Ind. Pharm., 2001; 27, 419-430. Go to original source... Go to PubMed...
    41. Lindner, W. D., Möckel, J. E., Lippold, B. C.: Pharmazie, 1996; 51, 263-272.
    42. Zuleger, S., Lippold, B. C.: Int. J. Pharm., 2001; 217, 139-152. Go to original source... Go to PubMed...
    43. Welch, K., Stromme, M.: J. Pharm. Sci.,2003; 92, 1242-1249. Go to original source... Go to PubMed...
    44. Ford, J. L. et al.: Int. J. Pharm., 1991; 71, 95-104. Go to original source...
    45. Zatloukal, Z.: âes. slov. Farm., 2004; 53, 332-335.
    46. Zatloukal, Z.: âes. slov. Farm., 1996; 45, 191-195.
    47. De Muth, J. E.: Basic statistics and pharmaceutical statistical applications. 1. ed., New York, Marcel Dekker, Inc., 1999.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.